You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Current Aims and Challenges Associated With Cervical Cancer Prevention

LONKY, NEAL M. MD, MPH*,†; PENNER, KRISTINE R. MD, MPH; DIEDRICH, JUSTIN T. MD§

Clinical Obstetrics & Gynecology:
doi: 10.1097/GRF.0000000000000026
Preventing Morbidity and Mortality from Cervical Cancer in the New Millennium
Abstract

This chapter will review the current modalities available to the clinician to screen for premalignant and malignant cervical lesions, which cast a broad net. The majority who test positive are not destined to suffer from or die from cervical cancer. Many who undergo screening and are triaged are young and subsequently face a number of aggressive and destructive therapies. This calls into question whether higher-risk patients should be managed more aggressively than an average-risk patient represented in the study population used to craft the guidelines.

Author Information

*Southern California Permanente Medical Group, Kaiser Permanente, Anaheim, California

Department of Obstetrics and Gynecology, University of California, Irvine, California

Department of Gynecologic Oncology, University of California Irvine School of Medicine, Irvine, California

§Washington University in St. Louis, St Louis, Missouri

The authors declare that they have nothing to disclose.

Correspondence: Neal Lonky, MD, MPH, Southern California Permanente Medical Group, Kaiser Permanente: Medical Office Building 2, 3430 E. La Palma Avenue, Anaheim, CA 92806. E-mail: nlonky@yahoo.com

© 2014 by Lippincott Williams & Wilkins.